AMIKACIN SULFATE INJECTION
JAMP PHARMA CORPORATION
Quick answers
Is there a shortage of AMIKACIN SULFATE INJECTION in Canada?
No. There is no current shortage of AMIKACIN SULFATE INJECTION 250MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
AMIKIN
BRISTOL-MYERS SQUIBB CANADA
AMIKACIN SULFATE INJECTION
HIKMA CANADA LIMITED
Other Products
AMIKACIN SULFATE INJECTION USP
SANDOZ CANADA INCORPORATED
VPI-AMIKACIN
VPI PHARMACEUTICALS INC
DIN
02529459
Strength
250MG
Dosage Form
Solution
Route
Intramuscular Intravenous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from JAMP PHARMA CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
225MG · DIN 02420694
50MG · DIN 02423227
2.5MG · DIN 02492199
10MG · DIN 02429225
5MG · DIN 02429217
DIN 02532174
DIN 02532182
500MG · DIN 02523825
2MG · DIN 02553341
100MG · DIN 02509172
25MG · DIN 02509164
10MG · DIN 02361450